FDA Adverse Event Injury Summary report: N

STIMWAVE STQ4

MDR report key: 18418255 · Received December 28, 2023

Report

Report Number
MW5149658
Event Type
Injury
Date Received
December 28, 2023
Date of Event
December 21, 2023
Report Date
December 26, 2023
Manufacturer
STIMWAVE/CURONIX LLC
Product Code
GZF
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
MA, US
Reporter Occupation
PATIENT
Health Professional
*

Narratives

Description of Event or Problem · 0

SAW ON THE NEWS THAT STIMWAVE HAS FILED FOR BANKRUPTCY IN 2022 AND THE CEO WAS ARRESTED FOR VARIOUS TYPES OF FRAUD, I.E. INSURANCE ETC. ALL STIMWAVE DEVICES BASED ON MY OWN RESEARCH HAS SHOWN THAT MY PARTICULAR DEVICE IS ON THE FDA RECALL LIST. THE DEVICE NEVER REALLY WORKED TO RELIEVE MY PAIN. I REACHED OUT TO THE COMPANY THAT HAS TAKEN OVER FOR STIMWAVE ON 12/26/2013 AND THEY HAVE MY FILE AND THEY ARE WORKING ON HAVING SOMEONE CONTACT ME WITH FURTHER GUIDANCE REGARDING THIS MATTER. REFERENCE REPORT: #MW5149659.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2017678 STIMWAVE STQ4 STIMULATOR, PERIPHERAL NERVE, IMPLANTED (PAIN RELIEF) GZF STIMWAVE/CURONIX LLC STQ4-RCV-A0/

Patients

Seq Age Sex Outcome Treatment
1 50 YR Male Required Intervention COMBIVENT.| DEXILANT.| DULERA.| EFFEXOR. | FAMOTIDINE.| FINASTERIDE. | LATANAPROST.| LINZESS.| PREGABALIN.| PROPRANOLOL.| RESPIMAT.| STIMWAVE. | TRAZODONE.